Stephens Inc Astrazeneca PLC Transaction History

Stephens Inc

$7.43 Billion
Q3 2025

A detailed history of Stephens Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Stephens Inc holds 23,418 shares of AZN stock, worth $1.93 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

23,418

Previous 23,496 0.33%

Holding current value

$1.93 Million

Previous $1.64 Million 9.45%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 27, 2025	SELL	$68.72 - $82.11 $5,360 - $6,404	-78 Reduced 0.33%	23,418 $1.8 Million
Q2 2025 Jul 29, 2025	BUY	$64.87 - $75.0 $1,686 - $1,950	26 Added 0.11%	23,496 $1.64 Million
Q1 2025 May 01, 2025	SELL	$65.37 - $77.96 $99,166 - $118,265	-1,517 Reduced 6.07%	23,470 $1.73 Million
Q4 2024 Jan 28, 2025	SELL	$63.2 - $79.58 $85,952 - $108,228	-1,360 Reduced 5.16%	24,987 $1.64 Million
Q3 2024 Oct 28, 2024	SELL	$76.67 - $87.62 $18,094 - $20,678	-236 Reduced 0.89%	26,347 $2.05 Million
Q2 2024 Aug 06, 2024	BUY	$66.81 - $80.83 $41,355 - $50,033	619 Added 2.38%	26,583 $2.07 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $25,998 - $29,636	-426 Reduced 1.61%	25,964 $1.76 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $252,201 - $282,316	4,075 Added 18.26%	26,390 $1.78 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $65,693 - $72,632	1,013 Added 4.76%	22,315 $1.51 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $2,237 - $2,425	32 Added 0.15%	21,302 $1.52 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $39,468 - $44,750	625 Added 3.03%	21,270 $1.48 Million
Q4 2022 Jan 25, 2023	BUY	$54.21 - $70.44 $62,395 - $81,076	1,151 Added 5.9%	20,645 $1.4 Million
Q3 2022 Nov 02, 2022	SELL	$53.02 - $135.75 $21,473 - $54,978	-405 Reduced 2.04%	19,494 $1.07 Million
Q2 2022 Aug 03, 2022	SELL	$59.26 - $71.14 $10,014 - $12,022	-169 Reduced 0.84%	19,899 $1.32 Million
Q1 2022 May 04, 2022	SELL	$55.72 - $67.12 $12,425 - $14,967	-223 Reduced 1.1%	20,068 $1.33 Million
Q4 2021 Mar 07, 2022	SELL	$54.02 - $63.83 $1,944 - $2,297	-36 Reduced 0.18%	20,291 $1.18 Million
Q3 2021 Oct 27, 2021	BUY	$55.56 - $60.79 $201,182 - $220,120	3,621 Added 21.67%	20,327 $1.22 Million
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $36,266 - $45,074	749 Added 4.69%	16,706 $1 Million
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $107,996 - $124,667	-2,290 Reduced 12.55%	15,957 $793,000
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $3,639 - $4,351	75 Added 0.41%	18,247 $912,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $113,569 - $130,754	2,140 Added 13.35%	18,172 $996,000
Q2 2020 Aug 24, 2020	SELL	$43.1 - $55.31 $5,689 - $7,300	-132 Reduced 0.82%	16,032 $848,000
Q1 2020 May 14, 2020	SELL	$37.79 - $51.33 $22,938 - $31,157	-607 Reduced 3.62%	16,164 $722,000
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $44,328 - $52,680	-1,044 Reduced 5.86%	16,771 $836,000
Q3 2019 Oct 18, 2019	SELL	$40.12 - $45.47 $709,762 - $804,409	-17,691 Reduced 49.83%	17,815 $794,000
Q2 2019 Aug 01, 2019	SELL	$37.28 - $41.68 $179,876 - $201,106	-4,825 Reduced 11.96%	35,506 $1.47 Million
Q1 2019 May 03, 2019	SELL	$35.49 - $43.02 $2.01 Million - $2.43 Million	-56,534 Reduced 58.36%	40,331 $1.63 Million
Q4 2018 Feb 11, 2019	SELL	$36.86 - $41.49 $565,137 - $636,124	-15,332 Reduced 13.67%	96,865 $3.68 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $3.15 Million - $3.6 Million	-90,755 Reduced 44.72%	112,197 $4.44 Million
Q2 2018 Aug 10, 2018	BUY	$34.55 - $37.05 $7.01 Million - $7.52 Million	202,952 New	202,952 $7.13 Million

Others Institutions Holding AZN

# of Institutions

1,449

Shares Held

489M

Call Options Held

7.22M

Put Options Held

2.57M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $255B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account